Halozyme Therapeutics HALO 130.34 1.72 1.34%
Expected move
November 04, 2026 close · $130.26| Horizon | Expected move | Typical range | 2 in 3 closes | 9 in 10 closes |
|---|---|---|---|---|
| Next session | ±1.9% ±$2.53 | $127.74 – $132.79 | $127.23 – $133.30 | $124.85 – $135.68 |
| 2 sessions | ±2.7% ±$3.52 | $126.75 – $133.78 | $126.01 – $134.52 | $122.70 – $137.83 |
| 3 sessions | ±3.4% ±$4.42 | $125.85 – $134.68 | $124.99 – $135.54 | $120.85 – $139.68 |
| 1 week | ±4.3% ±$5.62 | $124.65 – $135.88 | $123.39 – $137.14 | $118.29 – $142.24 |
| 2 weeks | ±6.0% ±$7.89 | $122.38 – $138.15 | $120.51 – $140.02 | $113.43 – $147.10 |
| 3 weeks | ±7.5% ±$9.77 | $120.50 – $140.03 | $118.12 – $142.41 | $109.63 – $150.90 |
| 1 month | ±8.9% ±$11.64 | $118.63 – $141.90 | $115.74 – $144.79 | $105.61 – $154.92 |
Earnings: priced against what happened
Average implied move
±7.01%
Average actual move
3.17%
Beyond the implied move
1 / 3
Median IV change
-13.66%
| Reaction session | Implied | Actual | Used | ATM IV before → after |
|---|---|---|---|---|
| May 12, 2026 | ±6.10% | +6.81% | 1.12× | — |
| August 06, 2025 | ±7.69% | +2.48% | 0.32× | — |
| February 19, 2025 | ±7.25% | -0.22% | 0.03× | 38.2% → 33.0% |